Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents and in combined treatment with cisplatin in ovarian cancer

по Zanjirband, Maryam, Edmondson, Richard J., Lunec, John
Опубликовано в: Oncotarget (2016)

Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer

по Zanjirband, Maryam, Curtin, Nicola, Edmondson, Richard J., Lunec, John
Опубликовано в: Oncotarget (2017)

DNA damage repair in ovarian cancer: unlocking the heterogeneity

по Gee, Mary Ellen, Faraahi, Zahra, McCormick, Aiste, Edmondson, Richard J.
Опубликовано в: J Ovarian Res (2018)

Engineering microrobots for targeted cancer therapies from a medical perspective

по Schmidt, Christine K., Medina-Sánchez, Mariana, Edmondson, Richard J., Schmidt, Oliver G.
Опубликовано в: Nat Commun (2020)

Epithelial ovarian cancer risk: A review of the current genetic landscape

по Flaum, Nicola, Crosbie, Emma J., Edmondson, Richard J., Smith, Miriam J., Evans, Dafydd G.
Опубликовано в: Clin Genet (2019)

First-Line Management of Advanced High-Grade Serous Ovarian Cancer

по Mahmood, Reem D., Morgan, Robert D., Edmondson, Richard J., Clamp, Andrew R., Jayson, Gordon C.
Опубликовано в: Curr Oncol Rep (2020)

PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer

по Morgan, Robert D., Clamp, Andrew R., Evans, D. Gareth R., Edmondson, Richard J., Jayson, Gordon C.
Опубликовано в: Cancer Chemother Pharmacol (2018)

Interventions for weight reduction in obesity to improve survival in women with endometrial cancer

по Kitson, Sarah, Ryan, Neil, MacKintosh, Michelle L, Edmondson, Richard, Duffy, James MN, Crosbie, Emma J
Опубликовано в: Cochrane Database Syst Rev (2018)

A Prospective Study to Identify Rates of SARS-CoV-2 Virus in the Peritoneum and Lower Genital Tract of Patients Having Surgery: An Observational Study

по Jones, Dominique, Faluyi, David, Hamilton, Sarah, Stylianides, Nicholas, Ma, Ken, Duff, Sarah, Machin, Nicholas, Edmondson, Richard J.
Опубликовано в: J Minim Invasive Gynecol (2021)

Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study

по Hawarden, Amy, Russell, Bryn, Gee, Mary Ellen, Skayali, Fatima, Clamp, Andrew, Crosbie, Emma Jayne, Edmondson, Richard John
Опубликовано в: BMC Cancer (2021)

Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study

по Hawarden, Amy, Russell, Bryn, Gee, Mary Ellen, Kayali, Fatima, Clamp, Andrew, Crosbie, Emma Jayne, Edmondson, Richard John
Опубликовано в: BMC Cancer (2021)

Ex vivo expanded tumour-infiltrating lymphocytes from ovarian cancer patients release anti-tumour cytokines in response to autologous primary ovarian cancer cells

по Owens, Gemma L., Price, Marcus J., Cheadle, Eleanor J., Hawkins, Robert E., Gilham, David E., Edmondson, Richard J.
Опубликовано в: Cancer Immunol Immunother (2018)

Prognostic models for predicting recurrence and survival in women with endometrial cancer

по Wan, Y Louise, El Sayed, Iman, Walker, Thomas DJ, Russell, Bryn, Badrick, Ellena, McAleenan, Alexandra, Edmondson, Richard, Crosbie, Emma J
Опубликовано в: Cochrane Database Syst Rev (2021)

The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: A prospective case control study

по Kitson, Sarah J., Lindsay, Jennifer, Sivalingam, Vanitha N., Lunt, Mark, Ryan, Neil A.J., Edmondson, Richard J., Rutter, Martin K., Crosbie, Emma J.
Опубликовано в: Gynecol Oncol (2018)

Ovarian Cancers Harbour Defects in Non-Homologous End Joining Resulting in Resistance to Rucaparib

по McCormick, Aiste, Donoghue, Peter, Dixon, Michelle, O’Sullivan, Richard, O’Donnell, Rachel L, Murray, James, Kaufmann, Angelika, Curtin, Nicola J, Edmondson, Richard J
Опубликовано в: Clin Cancer Res (2016)

Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian Cancer

по Owens, Gemma L., Sheard, Victoria E., Kalaitsidou, Milena, Blount, Daniel, Lad, Yatish, Cheadle, Eleanor J., Edmondson, Richard J., Kooner, Gurdeep, Gilham, David E., Harrop, Richard
Опубликовано в: J Immunother (2018)

BRCA1 and BRCA2 pathogenic variant carriers and endometrial cancer risk: A cohort study

по Kitson, Sarah J., Bafligil, Cemsel, Ryan, Neil A.J., Lalloo, Fiona, Woodward, Emma R., Clayton, Richard D., Edmondson, Richard J., Bolton, James, Crosbie, Emma J., Evans, D. Gareth
Опубликовано в: Eur J Cancer (2020)

The Use of Ovarian Cancer Cells from Patients Undergoing Surgery to Generate Primary Cultures Capable of Undergoing Functional Analysis

по O′Donnell, Rachel L., McCormick, Aiste, Mukhopadhyay, Asima, Woodhouse, Laura C., Moat, Madeleine, Grundy, Anna, Dixon, Michelle, Kaufman, Angelika, Soohoo, San, Elattar, Ahmed, Curtin, Nicola J., Edmondson, Richard J.
Опубликовано 2014

Functional characterisation of a novel ovarian cancer cell line, NUOC-1

по McCormick, Aiste, Earp, Eleanor, Elliot, Katherine, Cuthbert, Gavin, O'Donnell, Rachel, Wilson, Brian T., Sutton, Ruth, Leeson, Charlotte, Thomas, Huw D., Blair, Helen, Fordham, Sarah, Lunec, John, Allan, James, Edmondson, Richard J.
Опубликовано в: Oncotarget (2017)

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low l...

по Crosbie, Emma J., Flaum, Nicola, Harkness, Elaine F., Clayton, Richard D., Holland, Cathrine, Martin‐Hirsch, Pierre, Wood, Nick, Keating, Patrick, Woodward, Emma R., Lalloo, Fiona, Donnai, Paul, Edmondson, Richard J., Evans, D. Gareth
Опубликовано в: Int J Cancer (2020)